Journal
CHEST
Volume 126, Issue 1, Pages 78S-92SPublisher
ELSEVIER SCIENCE BV
DOI: 10.1378/chest.126.1_suppl.78S
Keywords
cardiopulmonary exercise testing; echocardiography; epoprostenol; functional class; hemodynamics; prognosis; pulmonary hypertension; 6 min walk test; survival; vasoreactivity
Categories
Ask authors/readers for more resources
Although idiopathic pulmonary arterial hypertension is perceived as a progressive disease with a uniformly poor outcome, the natural history of disease is heterogeneous, with some patients dying within months of diagnosis and others living for decades. The course of the disease has also been altered by advances in medical therapies. The outcome of patients with other types of pulmonary arterial hypertension (PAH) has been less well characterized. Assessment of prognosis of such patients is important, as it influences both medical therapy and referral for transplantation. This chapter will provide evidence based recommendations to assess the prognosis of patients with PAH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available